The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-002410 from 31.03.2014 issued to Novartis Pharma AG, Switzerland):
Reasans® (trade name of the drug)
Serlaxin (international non-proprietary or grouping or chemical name)
concentrate for solution for infusion, 3.5 mg / 3.5 ml (dosage form, dosage)
Novartis Pharma Stein AG, Switzerland Scaffhauserstrasse, 4332 Stein, Switzerland (name and address of the location of the manufacturer of the medicinal product)
on the basis of filing an application by the authorized legal entity Novartis Pharma LLC to cancel the state registration of the medicinal product.